MedSci Healthcare (HKG:2415) expects an attributable profit of not less than 10 million yuan for the first half, compared with 200,000 yuan a year earlier, according to a Wednesday Hong Kong bourse filing.
Shares of the online physician platform lost nearly 4% in Thursday's late afternoon trade.
The company said the surge was driven by stronger demand for precision omni-channel marketing in China's pharmaceutical sector, improved production efficiency through artificial intelligence, and tighter cost controls under its ESG initiatives.